Position in NVS
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$3,228,371
+$352,541 QoQ
Shares Held
21,135
+1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DGS Capital Management, LLC holds $21,433,187 across 14 Drug Manufacturers - General names. NVS ranks #2 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,631 | $3,331,961 | |
| 2 | NVS |
Novartis AG
This page
|
21,135 | $3,228,371 | |
| 3 | LLY |
ELI LILLY & Co
|
3,475 | $3,196,200 | |
| 4 | GSK |
GSK plc
|
42,695 | $2,356,337 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
14,029 | $1,955,221 | |
| 6 | MRK |
Merck & Co., Inc.
|
14,018 | $1,686,225 | |
| 7 | ABBV |
AbbVie Inc.
|
6,748 | $1,467,622 | |
| 8 | NVO |
Novo Nordisk A S
|
31,948 | $1,174,089 |
All Filings in NVS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,228,371 | 21,135 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,875,830 | 20,859 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $2,529,662 | 19,726 | Shares | Sole | 2026-02-24 | |
| 2025-06-30 | $2,248,365 | 18,580 | Shares | Sole | 2026-02-24 | |
| 2025-03-31 | $1,680,226 | 15,072 | Shares | Sole | 2026-02-24 | |
| 2024-12-31 | $1,226,203 | 12,601 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,228,758 | 10,683 | Shares | Sole | 2024-12-10 | |
| 2024-06-30 | $1,080,675 | 10,151 | Shares | Sole | 2024-12-10 | |
| 2024-03-31 | $909,939 | 9,407 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $939,525 | 9,305 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $889,135 | 8,729 | Shares | Sole | 2024-01-30 | |
| 2023-06-30 | $835,938 | 8,284 | Shares | Sole | 2024-01-30 | |
| 2023-03-31 | $774,824 | 8,422 | Shares | Sole | 2023-06-16 | |
| 2022-12-31 | $1,043,824 | 11,506 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $792,632 | 10,428 | Shares | Sole | 2023-02-21 | |
| 2022-06-30 | $1,114,528 | 13,185 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,058,967 | 12,068 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $479,947 | 5,487 | Shares | Sole | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||